These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 17396621)

  • 1. Pharmacokinetics of tilidine and naloxone in patients with severe hepatic impairment.
    Brennscheidt U; Brunnmüller U; Proppe D; Thomann P; Seiler KU
    Arzneimittelforschung; 2007; 57(2):106-11. PubMed ID: 17396621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability investigation of a new tilidine/naloxone liquid formulation compared to a reference formulation.
    Martin W; Ring J; Gaupp M; Arnold P; Sennewald R; Doser K
    Arzneimittelforschung; 1999 Jul; 49(7):599-607. PubMed ID: 10442208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics of nortilidine and naloxone after administration of tilidine/naloxone solution or tilidine/naloxone sustained release tablets.
    Brennscheidt U; Seiler KU; Thomann P
    Arzneimittelforschung; 2000 Nov; 50(11):1015-22. PubMed ID: 11148857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of CYP2C19 and CYP3A4 to the formation of the active nortilidine from the prodrug tilidine.
    Grün B; Merkel U; Riedel KD; Weiss J; Mikus G
    Br J Clin Pharmacol; 2012 Nov; 74(5):854-63. PubMed ID: 22381043
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics of tilidine in terminal renal failure.
    Seiler KU; Jähnchen E; Trenk D; Brennscheidt U; Heintz B
    J Clin Pharmacol; 2001 Jan; 41(1):79-84. PubMed ID: 11144998
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pre-systemic elimination of tilidine: localization and consequences for the formation of the active metabolite nortilidine.
    Eichbaum C; Mathes K; Burhenne J; Markert C; Blank A; Mikus G
    Basic Clin Pharmacol Toxicol; 2015 Feb; 116(2):129-33. PubMed ID: 25223231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sequential first-pass metabolism of nortilidine: the active metabolite of the synthetic opioid drug tilidine.
    Hajda JP; Jähnchen E; Oie S; Trenk D
    J Clin Pharmacol; 2002 Nov; 42(11):1257-61. PubMed ID: 12412825
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of the active principle of the weak opioid tilidine by the triazole antifungal voriconazole.
    Grün B; Krautter S; Riedel KD; Mikus G
    Br J Clin Pharmacol; 2009 Nov; 68(5):712-20. PubMed ID: 19916995
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmacokinetic aspects of the Valoron-N principle. Balanced pharmacokinetics of nortilidine and naloxone].
    Vollmer KO
    Fortschr Med; 1988 Oct; 106(29):593-6. PubMed ID: 3234997
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetics of tilidine and metabolites in man.
    Vollmer KO; Thomann P; Hengy H
    Arzneimittelforschung; 1989 Oct; 39(10):1283-8. PubMed ID: 2610722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Poisoning with tilidine and naloxone: toxicokinetic and clinical observations.
    Regenthal R; Krüger M; Richter M; Preiss R
    Hum Exp Toxicol; 1998 Nov; 17(11):593-7. PubMed ID: 9865414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of tilidine/naloxone, tramadol and bromfenac in experimental pain: a double-blind randomized crossover study in healthy human volunteers.
    Högger P; Rohdewald P
    Int J Clin Pharmacol Ther; 1999 Aug; 37(8):377-85. PubMed ID: 10475140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Management of chronic pain using extended release tilidine : Quality of life and implication of comedication on tilidine metabolism].
    Wolfert C; Merbach M; Stammler G; Emrich O; Meid AD; Burhenne J; Blank A; Mikus G
    Schmerz; 2017 Oct; 31(5):516-523. PubMed ID: 28597312
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro identification of the cytochrome P450 isozymes involved in the N-demethylation of the active opioid metabolite nortilidine to bisnortilidine.
    Wustrow I; Riedel KD; Mikus G; Weiss J
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Jun; 385(6):633-9. PubMed ID: 22349139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Actions of tilidine and nortilidine on cloned opioid receptors.
    Thierry C; Boeynaems JM; Paolo M
    Eur J Pharmacol; 2005 Jan; 506(3):205-8. PubMed ID: 15627429
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of tramadol and tilidine/naloxone on oral-caecal transit and pupillary light reflex.
    Freye E; Latasch L
    Arzneimittelforschung; 2000 Jan; 50(1):24-30. PubMed ID: 10683712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetics after a single dose of naloxone administered as a nasal spray in healthy volunteers.
    Vanky E; Hellmundt L; Bondesson U; Eksborg S; Lundeberg S
    Acta Anaesthesiol Scand; 2017 Jul; 61(6):636-640. PubMed ID: 28444856
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rapid quantification of tilidine, nortilidine, and bisnortilidine in urine by automated online SPE-LC-MS/MS.
    Köhler C; Grobosch T; Binscheck T
    Anal Bioanal Chem; 2011 Apr; 400(1):17-23. PubMed ID: 21140136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gas-chromatographic determination of nanogram amounts of enantiomers of nortilidine, a main metabolite of tilidine, in biological specimens.
    Hengy H; Vollmer KO; Gladigau V
    Clin Chem; 1978 Apr; 24(4):692-7. PubMed ID: 639277
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The opiate-like action of tilidine is mediated by metabolites.
    Schulz R; Bläsig J; Wüster M; Herz A
    Naunyn Schmiedebergs Arch Pharmacol; 1978 Sep; 304(2):89-93. PubMed ID: 212687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.